These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9857610)

  • 21. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-ordinate expression of virulence genes during swarm-cell differentiation and population migration of Proteus mirabilis.
    Allison C; Lai HC; Hughes C
    Mol Microbiol; 1992 Jun; 6(12):1583-91. PubMed ID: 1495387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Swarmer cell differentiation in Proteus mirabilis.
    Rather PN
    Environ Microbiol; 2005 Aug; 7(8):1065-73. PubMed ID: 16011745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some biological features of proteus bacilli. 3. Comparison of haemolytic activity of Proteus and Serratia strains.
    Rózalski A; Wykrota M
    Acta Microbiol Pol; 1986; 35(1-2):57-9. PubMed ID: 2426926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggregative adherence of uropathogenic Proteus mirabilis to cultured epithelial cells.
    Rocha SP; Elias WP; Cianciarullo AM; Menezes MA; Nara JM; Piazza RM; Silva MR; Moreira CG; Pelayo JS
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):319-26. PubMed ID: 17714491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells.
    Bishop BL; Duncan MJ; Song J; Li G; Zaas D; Abraham SN
    Nat Med; 2007 May; 13(5):625-30. PubMed ID: 17417648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotyping demonstrates that the strains of Proteus mirabilis from bladder stones and catheter encrustations of patients undergoing long-term bladder catheterization are identical.
    Sabbuba NA; Stickler DJ; Mahenthiralingam E; Painter DJ; Parkin J; Feneley RC
    J Urol; 2004 May; 171(5):1925-8. PubMed ID: 15076313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Observations on the adherence of Proteus mirabilis onto polymer surfaces.
    Stickler DJ; Lear JC; Morris NS; Macleod SM; Downer A; Cadd DH; Feast WJ
    J Appl Microbiol; 2006 May; 100(5):1028-33. PubMed ID: 16630003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laser interferometric and cultivation methods for measurement of colistin/ampicilin and saponin interactions with smooth and rough of Proteus mirabilis lipopolysaccharides and cells.
    Arabski M; Wasik S; Dworecki K; Kaca W
    J Microbiol Methods; 2009 May; 77(2):178-83. PubMed ID: 19318050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caspase-3-dependent apoptosis in Escherichia coli-infected urothelium: involvement of inducible nitric oxide synthase.
    Andersson M; Poljakovic M; Persson K
    BJU Int; 2006 Jul; 98(1):160-5. PubMed ID: 16831162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of influence of Proteus mirabilis LPS polysaccharide part on the murine immune cells activation.
    Klink M; Sonn CH; Kaca W; Kim YS
    Arch Immunol Ther Exp (Warsz); 1999; 47(3):195-201. PubMed ID: 10470447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement activation by Proteus mirabilis negatively charged lipopolysaccharides.
    Kaca W; Literacka E; Sjöholm AG; Weintraub A
    J Endotoxin Res; 2000; 6(3):223-34. PubMed ID: 11052177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The binding of Proteus mirabilis nonagglutinating fimbriae to ganglio-series asialoglycolipids and lactosyl ceramide.
    Lee KK; Harrison BA; Latta R; Altman E
    Can J Microbiol; 2000 Oct; 46(10):961-6. PubMed ID: 11068685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxinogenic potential of Proteus mirabilis strains.
    Hostacká A; Ciznár I; Markovic J; Karolcek J
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):83-92. PubMed ID: 6431715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies of correlative relations between virulence and other biological properties of Proteus].
    Vitvits'kii VM; Dikii BM
    Mikrobiol Zh; 1975; 37(6):748-51. PubMed ID: 1107766
    [No Abstract]   [Full Text] [Related]  

  • 36. [The protective activity of anti-Proteus blood preparations].
    Nazarchuk LV; Koval' AI
    Fiziol Zh (1994); 1999; 45(6):37-9. PubMed ID: 10687080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations of M(2)-muscarinic receptor protein and mRNA expression in the urothelium and muscle layer of the streptozotocin-induced diabetic rat urinary bladder.
    Tong YC; Cheng JT; Hsu CT
    Neurosci Lett; 2006 Oct; 406(3):216-21. PubMed ID: 16935418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A structured-population model of Proteus mirabilis swarm-colony development.
    Ayati BP
    J Math Biol; 2006 Jan; 52(1):93-114. PubMed ID: 16283413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation.
    Simeonova PP; Wang S; Toriuma W; Kommineni V; Matheson J; Unimye N; Kayama F; Harki D; Ding M; Vallyathan V; Luster MI
    Cancer Res; 2000 Jul; 60(13):3445-53. PubMed ID: 10910055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study of the experimental pathogenic action of Proteus].
    Lukach IG; Varshteĭn IuA
    Mikrobiol Zh; 1974; 36(1):86-9. PubMed ID: 4601302
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.